NCT04281407 is a NA clinical trial of Visbiome in Metabolism, sponsored by University of Washington.

Who is sponsoring NCT04281407?

NCT04281407 is sponsored by University of Washington.

What drugs are being tested in NCT04281407?

Interventions in NCT04281407: Visbiome.

What condition does NCT04281407 study?

NCT04281407 studies Metabolism.

Is NCT04281407 still recruiting?

NCT04281407 is currently status unknown. Last updated 24 February 2020.

Last reviewed 2020-02-24 · How we verify

NCT04281407

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism

Status unknown NA Last updated 24 February 2020

What this trial tests

NA trial testing Visbiome in Metabolism in 12 participants. Status unknown.

Timeline

3 January 2020

Primary endpoint
30 June 2020

31 August 2020

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	3 January 2020
Primary completion	30 June 2020
Estimated completion	31 August 2020
Sites	1 location across United States

Drugs / interventions tested

Visbiome — full drug profile →

Conditions studied

Metabolism — all drugs for Metabolism →

Sponsor

University of Washington

Who can join

Adults 18 to 40, male only, with Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open-label, fixed sequence study of the effect of probiotics supplementation on drug, vitamin, and hormone metabolism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Visbiome

Trials testing the same drug.

NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
NCT04141761 — Probiotics in Newly Diagnosed T1D · Phase 2 · active not recruiting
NCT03524638 — Visbiome Effect on Colorectal Anastomosis and Local Recurrence · NA · withdrawn
NCT02441244 — Probiotic Visbiome for Inflammation and Translocation in HIV Ι · Phase 2 · terminated
NCT03078530 — Probiotic (Visbiome) for Gulf War Illness · Phase 2, PHASE3 · unknown

Other recruiting trials for Metabolism

Currently open trials in the same condition.

NCT06930976 — Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells · NA · recruiting
NCT07141537 — Caloric Balance Markers Study · recruiting
NCT06907329 — The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and · NA · recruiting
NCT06813261 — GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women · NA · recruiting
NCT06754709 — Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04281407 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 24 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04281407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing